The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Medy Tox competitive analysis

Loading summary...

Latest patents of Medy Tox opposed by its competitors

Explore Medy Tox's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP2692350
Jun 28, 2023Lyophilized Preparation Of Botulinum Toxin1
EP3079714
Nov 25, 2020Long Lasting Effect Of New Botulinum Toxin Formulations1

Latest PTAB cases involving Medy Tox

Discover the latest PTAB cases involving Medy Tox, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 14, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Medy Tox

IPR2021-01203Jul 1, 2021REVANCE THERAPEUTICSMEDY TOXInstitution Denied
IPR2021-01204Jul 1, 2021REVANCE THERAPEUTICSMEDY TOXInstitution Denied
PGR2019-00062Sep 4, 2019GALDERMAMEDY TOXFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Medy Tox with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MEDY TOX - 2 - 3
GALDERMA - - 4 -
IPSEN PHARMA33 - -
REVANCE THERAPEUTICS - 32 -